CPDD members can add events to the calendar. Submit your event here.
NABR Webinar: Q&A With the USDA - The 12th Edition NABR is once again pleased to announce the return of one of its most requested webinars, "Q&A with the USDA." Join USDA-APHIS Animal Care’s Drs. Elizabeth Theodorson, assistant deputy administrator for Animal Welfare Operations, and Dr. Louis DiVincenti, senior veterinary medical officer -research, for "Q&A with […]
Introduction to FDA’s Office of Trade and Global Partnerships July 23, 2024 – Webinar Introduction to FDA’s Office of Trade and Global Partnerships Learn about the FDA’s Office of Trade and Global Partnerships (OTGP) and how its work relates to pharmaceutical products. This discussion will also cover the different types of international agreements and arrangements […]
Environmental Monitoring in Compounding July 30, 2024 – Webinar Environmental Monitoring in Compounding Get an overview of environmental monitoring for compounding facilities and the role it plays in ensuring product quality and patient safety. Presenters will discuss statutory and regulatory requirements, expectations for compounding pharmacies and outsourcing facilities, and different methods specific to environmental monitoring. […]
Next National Advisory Council on Drug Abuse Meeting: September 11 The National Advisory Council on Drug Abuse (NACDA) serves a crucial role in advising NIDA, and, by extension, the Director, NIH and the Secretary, DHHS, as NIDA identifies, reviews, and supports the highest caliber of scientific research. The next NACDA meeting will take place Wednesday, […]
Electronic Drug Registration and Listing (eDRLS) Using CDER Direct - 2024 September 12, 2024 – Webinar 8:45 am-5:45pm Electronic Drug Registration and Listing (eDRLS) Using CDER Direct - 2024 This demonstration of how to submit establishment registration and drug listing data using CDER Direct will feature case studies for an interactive learning experience. LinkedIn: SBIA|Webinar: […]
Sex Differences in Addiction Workshop Organized in conjunction with ACU’s Healthy Brain and Mind Research Centre, experts from the National Institute on Drug Abuse, and the ENIGMA consortium When: Friday 27 September 2024 (1pm – 4.30pm PDT, see other timezones) Where: Online via Zoom Registration: https://forms.gle/LxCPPCPUVtpHL24n9 Find more info at: https://enigma.ini.usc.edu/events/upcoming-events/ Erynn, on behalf of the Sex Differences in Addiction Organising […]
NABR Webinar: “Current and Future Challenges Facing Biomedical Research” Please join us on Tuesday, Oct. 8, at 12:30 p.m. EST for the 61st NABR webinar when Matt Bailey, President of NABR and FBR; Brandon Morton, NABR’s Director of Government Affairs; and Taylor Bennett, NABR’s Senior Scientific Advisor, sit down to discuss the “Current and Future […]
Professional NIH Grant Development Live Online Workshop October 15-16, 2024 10:30 a.m. to 6:00 p.m. Eastern Time Sponsored by the Grant Training Center The Professional NIH Grant Development live online workshop, which is normally held at the University of Pennsylvania, has moved online. It will include the same content and length of instruction. You will […]
FROM THE NAADAC WEBSITE: Registration Information for the NAADAC 2024 Annual Conference & Hill Day Join us for the NAADAC 2024 Annual Conference & Hill Day: Learn, Connect, Advocate, Succeed, in the Washington, DC, area at the Gaylord National Resort & Convention Center from October 18 - 23, 2024. This year's conference will feature dozens of educational […]
FDA and NIH Joint Public Meeting on Advancing Smoking Cessation Priorities REGISTRATION IS OPEN On Monday, October 21, from 9 a.m. to 4:30 p.m. EDT, the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) will host a joint public meeting entitled, “Advancing Smoking Cessation: FDA and NIH Priorities.” The focus […]
Advancing Smoking Cessation: FDA and NIH Priorities Attend the joint public meeting hosted by the Food and Drug Administration (FDA) and the National Institutes of Health (NIH). Goals and Objectives: This public meeting will address the need for novel smoking cessation products to help individuals of all ages, including underserved and vulnerable populations, stop smoking. […]
Join January 16 FDA Grand Rounds - The PATH from Data to Action: Key Findings from the Population Assessment of Tobacco and Health Study to Inform FDA’s Regulatory Activities The Population Assessment of Tobacco and Health (PATH) Study, a national, longitudinal cohort study of tobacco use and health in the United States, is one of […]